A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer.
Yu W, Ye F, Yuan X, Ma Y, Mao C, Li X, Li J, Dai C, Qian F, Li J, Fan X, Zhou Y, Wang D, Guo Z, An H, Zhang M, Chen D, Xia S.
Yu W, et al. Among authors: wang d.
BMC Cancer. 2021 Jul 31;21(1):877. doi: 10.1186/s12885-021-08590-1.
BMC Cancer. 2021.
PMID: 34332557
Free PMC article.
Clinical Trial.